Item 7.01 Regulation FD Disclosure.

On January 7, 2021, Exicure, Inc. (the "Company") will host a virtual R&D Day on Thursday, January 7, 2021 from 9:00 am to 10:30 am ET to discuss its neuroscience pipeline, including its lead program for Friedreich's Ataxia (FA). The R&D Day webcast will include a slide presentation, which is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference in this Item 7.01. The R&D Day webcast will be available on the Company's website for 30 days following the event.

The information in this Item 7.01 to this Current Report on Form 8-K, and including Exhibit 99.1 furnished herewith, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

--------------------------------------------------------------------------------

Item 9.01 Financial Statements and Exhibits.


   Exhibit
     No.                                              Description
99.1                  Slide presentation to be presented at the Exicure, Inc. R&D Day on January 7,
                    2021.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses